Physician profile
Alexandra Larocca
NPI 1881009629
$2,016.87
in general payments reported to CMS, 2019-2025
14 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $192 · 2021: $444 · 2022: $334 · 2023: $513 · 2024: $33.28 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $970.98 | 2019-2025 | Apligraf, Puraply |
| Smith+Nephew, INC. | $250.91 | 2019-2023 | Collagenase Santyl |
| Tactile Systems Technology INC | $207.72 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Lifenet Health | $125.96 | 2023 | |
| Depuy Synthes Sales INC. | $124.57 | 2021 | |
| Integra Lifesciences Corporation | $111.56 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $57.49 | 2021-2022 | |
| Kerecis Limited | $45.49 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Solventum Corporation | $33.28 | 2024 | Activ.A.C. |
| Bioventus LLC | $21.64 | 2023 | |
| Osteomed LLC | $20.66 | 2021 | |
| Orthofix Medical, INC. | $20.34 | 2025 | Physio-Stim |
| Arthrosurface Incorporated | $13.25 | 2019 | |
| Melinta Therapeutics, LLC | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Larocca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.